Morgan Stanley Maintains Equal-Weight on Phibro Animal Health, Lowers Price Target to $16
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Erin Wright has maintained an Equal-Weight rating on Phibro Animal Health (NASDAQ:PAHC) and lowered the price target from $17 to $16.
November 09, 2023 | 2:32 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Morgan Stanley has maintained an Equal-Weight rating on Phibro Animal Health and lowered the price target from $17 to $16.
The lowering of the price target by Morgan Stanley indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on Phibro Animal Health's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100